Lipophagy is a type of selective autophagy that targets lipid droplets for degradation. Since the discovery of lipophagy in 2009, research has uncovered a central role for this process in cellular lipid metabolism, including in atherogenic foam cells. Therefore, increasing lipophagy might be a therapeutic target to reverse lipid build-up in atherosclerosis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CircKIAA1617 promotes stemness via USP14/PGRMC1-mediated autophagy and lipid metabolism reprogramming in ER-positive breast cancer
Molecular Cancer Open Access 31 January 2026
-
Astaxanthin and Dihydroartemisinin loaded PLGA NPs for atherosclerosis therapy via regulating lipid metabolism and immune microenvironment
Journal of Nanobiotechnology Open Access 01 December 2025
-
Lipid droplet dynamics in type 2 diabetes and its complications: pathophysiological insights and therapeutic options
Lipids in Health and Disease Open Access 23 September 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Robichaud, S. et al. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells. Autophagy 17, 3671–3689 (2021).
Pu, M. et al. ORP8 acts as a lipophagy receptor to mediate lipid droplet turnover. Protein Cell https://doi.org/10.1093/procel/pwac063 (2022).
Chung, J. et al. The Troyer syndrome protein spartin mediates selective autophagy of lipid droplets. Preprint at bioRxiv https://doi.org/10.1101/2021.08.18.456894 (2021).
Ouimet, M. et al. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab. 13, 655–667 (2011).
Razani, B. et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab. 15, 534–544 (2012).
Liao, X. et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 15, 545–553 (2012).
Sergin, I. et al. Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis. Nat. Commun. 8, 15750 (2017).
Dubland, J. A. et al. Low LAL (lysosomal acid lipase) expression by smooth muscle cells relative to macrophages as a mechanism for arterial foam cell formation. Arterioscler. Thromb. Vasc. Biol. 41, e354–e368 (2021).
Robichaud, S. et al. Autophagy is differentially regulated in leukocyte and nonleukocyte foam cells during atherosclerosis. Circ. Res. 130, 831–847 (2022).
Fu, Y. et al. Degradation of lipid droplets by chimeric autophagy-tethering compounds. Cell Res. 31, 965–979 (2021).
Acknowledgements
The authors were supported by the Canadian Institutes for Health Research (PJT-391187 and Canada Research Chair to M.O.), the Natural Sciences and Engineering Research Council of Canada (Discovery Grant to M.O.), and a University of Ottawa Cardiac Endowment Fellowship (to T.L.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Laval, T., Ouimet, M. A role for lipophagy in atherosclerosis. Nat Rev Cardiol 20, 431–432 (2023). https://doi.org/10.1038/s41569-023-00885-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41569-023-00885-z
This article is cited by
-
CircKIAA1617 promotes stemness via USP14/PGRMC1-mediated autophagy and lipid metabolism reprogramming in ER-positive breast cancer
Molecular Cancer (2026)
-
Astaxanthin and Dihydroartemisinin loaded PLGA NPs for atherosclerosis therapy via regulating lipid metabolism and immune microenvironment
Journal of Nanobiotechnology (2025)
-
Lipid droplet dynamics in type 2 diabetes and its complications: pathophysiological insights and therapeutic options
Lipids in Health and Disease (2025)
-
The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease
Journal of Translational Medicine (2025)
-
Recombinant high-density lipoprotein targeted delivery of celastrol to promote foam cells lipophagy against early atherosclerosis
Journal of Nanobiotechnology (2025)